Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)
Trial details
- Registry ID
- NCT04057040
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Rusfertide
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)NCT04057040 | PTGX | Phase 2 | Completed | 2023-02-14Actual |
| PTG-300 in Subjects With Hereditary HemochromatosisNCT04202965 | PTGX | Phase 2 | Completed | 2021-10-06Actual |
| PTG-300 in Patients With Polycythemia Vera and Elevated HematocritNCT04767802 | PTGX | Phase 2 | Completed | 2023-03-15Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |